首页> 外文学位 >Development of a vinylogous Horner-Wadsworth-Emmons reagent: Syntheses of siloxy dienes, aryl amines and medicinally active compounds.
【24h】

Development of a vinylogous Horner-Wadsworth-Emmons reagent: Syntheses of siloxy dienes, aryl amines and medicinally active compounds.

机译:乙烯基霍纳-沃兹沃斯-埃蒙斯试剂的开发:甲硅烷氧基二烯,芳基胺和药用活性化合物的合成。

获取原文
获取原文并翻译 | 示例

摘要

This thesis describes the progress on three different methodology projects and two multistep syntheses of a complex molecule. Specifically, we have synthesized a single isomer of a bis(siloxy)diene. To accomplish the synthesis of bis(siloxy)diene, we had to screen for conditions to produce a single isomer of its mono(silyl)enol ether. Additionally, a vinylogous Horner-Wadsworth-Emmons (HWE) reagent was developed, which can be used to provide 4-methyldienoates from an aldehyde starting material. With this HWE reagent, we have synthesized trichostatic acid through an improved method where the diene unit is installed in one step. Additionally we have used an analogous step-wise version of this synthesis to prepare trichostatin A. We have developed an efficient synthesis of 1-a-13, which allowed us to provide gram quantities of this pyrrolinone to our collaborators for biological evaluation as a Niemann-Pick type C disease (NP-C) therapeutic. We also discuss the synthesis of triazine 2-a-1, which was another NP-C drug candidate. We also report on the development of a new aryl amination protocol, which is able to transform aryl iodides, bromide, chloride, azides, and nitro compounds into the corresponding aryl amines. With this new method, we transformed 1-a-13 into the corresponding amine to establish an SAR for the pyrrolinones. This amine was converted into the corresponding azide 1-a-13-N3 for a photoaffinity labeling study.
机译:本文描述了复杂分子的三个不同方法学项目和两个多步合成的进展。具体而言,我们合成了双(甲硅烷氧基)二烯的单一异构体。为了完成双(甲硅烷氧基)二烯的合成,我们必须筛选产生单(甲硅烷基)烯醇醚的单一异构体的条件。另外,开发了乙烯基类的霍纳-沃兹沃思-埃蒙斯(HWE)试剂,该试剂可用于从醛原料中提供4-甲基二烯二酸酯。借助这种HWE试剂,我们通过一种改进的方法合成了三丁香酸,其中一步安装了二烯单元。此外,我们已经使用该合成的类似逐步方法来制备曲古抑菌素A。我们开发了1-a-13的有效合成方法,从而可以将克量的吡咯烷酮作为尼曼提供给我们的合作者进行生物学评估-选择C型疾病(NP-C)的治疗剂。我们还讨论了另一种NP-C候选药物三嗪2-a-1的合成。我们还报告了新的芳基胺化方案的发展,该方案能够将芳基碘化物,溴化物,氯化物,叠氮化物和硝基化合物转化为相应的芳基胺。使用这种新方法,我们将1-a-13转化为相应的胺以建立吡咯烷酮的SAR。该胺被转化为相应的叠氮化物1-a-13-N3,用于光亲和标记研究。

著录项

  • 作者

    Markiewicz, John T.;

  • 作者单位

    University of Notre Dame.;

  • 授予单位 University of Notre Dame.;
  • 学科 Chemistry Biochemistry.;Chemistry Organic.
  • 学位 Ph.D.
  • 年度 2011
  • 页码 399 p.
  • 总页数 399
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号